CN103270419B - 用于通过宫颈细胞的悬液样本预测受试者是否具有宫颈上皮内瘤样(cin)病变的方法和系统 - Google Patents

用于通过宫颈细胞的悬液样本预测受试者是否具有宫颈上皮内瘤样(cin)病变的方法和系统 Download PDF

Info

Publication number
CN103270419B
CN103270419B CN201180061996.1A CN201180061996A CN103270419B CN 103270419 B CN103270419 B CN 103270419B CN 201180061996 A CN201180061996 A CN 201180061996A CN 103270419 B CN103270419 B CN 103270419B
Authority
CN
China
Prior art keywords
cells
data
cervical
sample
biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180061996.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN103270419A (zh
Inventor
布鲁斯·K·帕特森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IncellDx Inc
Original Assignee
IncellDx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IncellDx Inc filed Critical IncellDx Inc
Priority to CN201711037694.6A priority Critical patent/CN107699618B/zh
Publication of CN103270419A publication Critical patent/CN103270419A/zh
Application granted granted Critical
Publication of CN103270419B publication Critical patent/CN103270419B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
CN201180061996.1A 2010-11-12 2011-11-10 用于通过宫颈细胞的悬液样本预测受试者是否具有宫颈上皮内瘤样(cin)病变的方法和系统 Expired - Fee Related CN103270419B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711037694.6A CN107699618B (zh) 2010-11-12 2011-11-10 非疾病诊断的确定宫颈上皮内瘤样(cin)细胞是否存在于来自受试者的标记液体宫颈细胞样本的方法和系统

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41330210P 2010-11-12 2010-11-12
US61/413,302 2010-11-12
US201161484142P 2011-05-09 2011-05-09
US61/484,142 2011-05-09
PCT/US2011/060270 WO2012065004A2 (en) 2010-11-12 2011-11-10 Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (cin) lesion from a suspension sample of cervical cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201711037694.6A Division CN107699618B (zh) 2010-11-12 2011-11-10 非疾病诊断的确定宫颈上皮内瘤样(cin)细胞是否存在于来自受试者的标记液体宫颈细胞样本的方法和系统

Publications (2)

Publication Number Publication Date
CN103270419A CN103270419A (zh) 2013-08-28
CN103270419B true CN103270419B (zh) 2017-12-05

Family

ID=46048105

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201180061996.1A Expired - Fee Related CN103270419B (zh) 2010-11-12 2011-11-10 用于通过宫颈细胞的悬液样本预测受试者是否具有宫颈上皮内瘤样(cin)病变的方法和系统
CN201711037694.6A Expired - Fee Related CN107699618B (zh) 2010-11-12 2011-11-10 非疾病诊断的确定宫颈上皮内瘤样(cin)细胞是否存在于来自受试者的标记液体宫颈细胞样本的方法和系统

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201711037694.6A Expired - Fee Related CN107699618B (zh) 2010-11-12 2011-11-10 非疾病诊断的确定宫颈上皮内瘤样(cin)细胞是否存在于来自受试者的标记液体宫颈细胞样本的方法和系统

Country Status (6)

Country Link
US (3) US10011884B2 (enExample)
EP (2) EP3217178A3 (enExample)
JP (3) JP6109744B2 (enExample)
CN (2) CN103270419B (enExample)
ES (1) ES2627069T3 (enExample)
WO (1) WO2012065004A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12018857B2 (en) 2008-06-13 2024-06-25 Kateeva, Inc. Gas enclosure assembly and system
US12064979B2 (en) 2008-06-13 2024-08-20 Kateeva, Inc. Low-particle gas enclosure systems and methods
US11975546B2 (en) 2008-06-13 2024-05-07 Kateeva, Inc. Gas enclosure assembly and system
US10434804B2 (en) 2008-06-13 2019-10-08 Kateeva, Inc. Low particle gas enclosure systems and methods
HK1218330A1 (zh) * 2013-01-14 2017-02-10 茵赛德斯有限公司 確定針對子宫頸癌是否應該測試子宫頸細胞樣本的方法及用於實施其的裝置和試劑盒
EP2973217B1 (en) * 2013-03-15 2023-10-25 Hologic, Inc. System and method for reviewing and analyzing cytological specimens
US10468279B2 (en) 2013-12-26 2019-11-05 Kateeva, Inc. Apparatus and techniques for thermal treatment of electronic devices
WO2015112454A1 (en) 2014-01-21 2015-07-30 Kateeva, Inc. Apparatus and techniques for electronic device encapsulation
WO2015168036A1 (en) 2014-04-30 2015-11-05 Kateeva, Inc. Gas cushion apparatus and techniques for substrate coating
WO2016014861A1 (en) 2014-07-25 2016-01-28 Incelldx, Inc. Methods of evaluating a cellular sample for latent cellular replication competent hiv-1, and compositions and kits for use in practicing the same
CA2961613A1 (en) * 2014-09-17 2016-03-24 Hologic, Inc. Method of partial lysis and assay
EP3304041B1 (en) * 2015-05-26 2021-03-10 IncellDx, Inc. Methods of assessing cellular breast samples and compositions for use in practicing the same
JP6938489B2 (ja) * 2015-10-23 2021-09-22 ノバルティス・エイジーＮｏｖａｒｔｉｓ ＡＧ 視野に存在する選択された細胞のバイオマーカー陽性率の値を導き出す方法
JP7260960B2 (ja) * 2018-03-29 2023-04-19 シスメックス株式会社 検体前処理装置、ロボットアームおよび検体前処理方法
US12020493B2 (en) 2018-07-27 2024-06-25 Ventana Medical Systems, Inc. Systems for automated in situ hybridization analysis
US10769784B2 (en) * 2018-12-21 2020-09-08 Metal Industries Research & Development Centre Image analyzing method and electrical device
CN114341614A (zh) * 2019-04-28 2022-04-12 Essenlix 公司 无冲洗的快速病理学/细胞学
CN110335686B (zh) * 2019-06-06 2023-07-04 广州金域医学检验中心有限公司 细胞类型识别方法、装置、计算机设备及存储介质
CN112529843A (zh) * 2020-11-23 2021-03-19 集美大学 一种用于识别异常上皮细胞的方法和系统

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006052822A2 (en) * 2004-11-05 2006-05-18 Cytolution, Inc. Methods and devices for screening cervical cancer
WO2006084155A1 (en) * 2005-02-02 2006-08-10 Patterson Bruce K Hpv e6, e7 mrna assay and methods of use thereof
CN101831490A (zh) * 2009-03-12 2010-09-15 上海市第八人民医院 一种利用pax1和cdh1基因甲基化检测宫颈癌的方法和试剂盒

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2955591A (en) 1954-05-20 1960-10-11 Kenneth S Maclean Abrasive cytologic instruments
US3626470A (en) 1969-08-28 1971-12-07 Armour Pharma Diagnostic device for obtaining cytologic samples
GB1408140A (en) 1971-12-09 1975-10-01 Levene M M Sampling device
US3877464A (en) 1972-06-07 1975-04-15 Andrew R Vermes Intra-uterine biopsy apparatus
US3815580A (en) 1972-08-31 1974-06-11 C Oster Apparatus for and method of collecting and preserving cytologic samples
US3945372A (en) 1973-06-01 1976-03-23 Milan Albert R Medical tissue-obtaining system
US4127113A (en) 1977-12-15 1978-11-28 Pap Smear Center, Inc. Multiple smear brush
US4175008A (en) 1978-06-26 1979-11-20 Bio-Pharmaceutical Packaging Corp. Culture specimen collection and transport package
JPS59109840A (ja) 1982-12-16 1984-06-25 Hitachi Koki Co Ltd 走査形電子顕微鏡用生物試料の前処理方法
US4862899A (en) 1985-05-02 1989-09-05 Bucaro Russell J Kit for home use detection of cervical and vaginal cancer
NL8503596A (nl) 1985-12-31 1987-07-16 Futura Nova Bv Inrichting voor het maken van een uitstrijk van een lichaamsholte.
US4745285A (en) 1986-08-21 1988-05-17 Becton Dickinson And Company Multi-color fluorescence analysis with single wavelength excitation
US4704891A (en) 1986-08-29 1987-11-10 Becton, Dickinson And Company Method and materials for calibrating flow cytometers and other analysis instruments
US4867908A (en) 1986-08-29 1989-09-19 Becton, Dickinson And Company Method and materials for calibrating flow cytometers and other analysis instruments
US4762133A (en) 1987-03-20 1988-08-09 Medical Dynamics, Inc. Cervical cytology device
US4873992A (en) 1987-03-20 1989-10-17 Medical Dynamics, Inc. Cervical cytology device
US4754764A (en) 1987-03-20 1988-07-05 Medical Dynamics, Inc. Cervical cytology device
US4953560A (en) 1989-12-07 1990-09-04 Bernard Samuels Apparatus, method, and test kit for diagnosis of vaginal yeast infections
IE76732B1 (en) 1990-08-07 1997-11-05 Becton Dickinson Co One step test for absolute counts
CA2087086A1 (en) 1992-01-22 1993-07-23 Leon Wmm Terstappen Multidimensional cell differential analysis
US5422277A (en) * 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface
US5342790A (en) 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
US5445164A (en) 1993-05-11 1995-08-29 Gynetech, Inc. Cervical tissue sampling device
US5787891A (en) 1995-03-16 1998-08-04 Sak; Robert Method and apparatus for sampling cervical tissue
US5620842A (en) 1995-03-29 1997-04-15 Becton Dickinson And Company Determination of the number of fluorescent molecules on calibration beads for flow cytometry
US5701012A (en) 1996-03-19 1997-12-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Fluorescent biological particle detection system
US5895922A (en) 1996-03-19 1999-04-20 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Fluorescent biological particle detection system
US5858683A (en) 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US5795309A (en) 1997-07-10 1998-08-18 Leet; Richard A. Cervical tissue sampling and containment device
US6256096B1 (en) 1999-01-11 2001-07-03 Softray Flow cytometry apparatus and method
US6249341B1 (en) 1999-01-25 2001-06-19 Amnis Corporation Imaging and analyzing parameters of small moving objects such as cells
US6707551B2 (en) 2000-01-24 2004-03-16 Amnis Corporation Multipass cavity for illumination and excitation of moving objects
US6473176B2 (en) 1999-01-25 2002-10-29 Amnis Corporation Imaging and analyzing parameters of small moving objects such as cells
US6608682B2 (en) 1999-01-25 2003-08-19 Amnis Corporation Imaging and analyzing parameters of small moving objects such as cells
US6975400B2 (en) 1999-01-25 2005-12-13 Amnis Corporation Imaging and analyzing parameters of small moving objects such as cells
US6671044B2 (en) 1999-01-25 2003-12-30 Amnis Corporation Imaging and analyzing parameters of small moving objects such as cells in broad flat flow
US7450229B2 (en) 1999-01-25 2008-11-11 Amnis Corporation Methods for analyzing inter-cellular phenomena
US6580504B1 (en) 1999-01-25 2003-06-17 Amnis Corporation Multipass cavity for illumination and excitation of moving objects
US7057732B2 (en) 1999-01-25 2006-06-06 Amnis Corporation Imaging platform for nanoparticle detection applied to SPR biomolecular interaction analysis
ATE466930T1 (de) 2000-06-21 2010-05-15 Qiagen Gaithersburg Inc Universelles sammelmedium
US6875973B2 (en) 2000-08-25 2005-04-05 Amnis Corporation Auto focus for a flow imaging system
JP4994560B2 (ja) 2000-08-25 2012-08-08 アムニス コーポレイション 細胞などの小さな移動物体の速度測定
US6778263B2 (en) 2000-08-25 2004-08-17 Amnis Corporation Methods of calibrating an imaging system using calibration beads
US6608680B2 (en) 2000-08-25 2003-08-19 Amnis Corporation TDI imaging system for kinetic studies
US6583865B2 (en) 2000-08-25 2003-06-24 Amnis Corporation Alternative detector configuration and mode of operation of a time delay integration particle analyzer
US6934408B2 (en) 2000-08-25 2005-08-23 Amnis Corporation Method and apparatus for reading reporter labeled beads
AU2002211913A1 (en) 2000-10-12 2002-04-22 Amnis Corporation Multipass cavity for illumination and excitation of moving objects
AU2001297843A1 (en) 2000-10-12 2002-12-23 Amnis Corporation Imaging and analyzing parameters of small moving objects such as cells
US6387058B1 (en) 2000-10-13 2002-05-14 Wallach Surgical Devices, Inc. Self-sampling brush and method for use
US6838248B2 (en) * 2000-11-17 2005-01-04 Biomoda, Inc. Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
US6329167B1 (en) 2000-12-05 2001-12-11 Bruce K. Patterson Method of testing adequacy of cells in a specimen
WO2002086416A2 (en) 2001-04-25 2002-10-31 Amnis Corporation Method and apparatus for correcting crosstalk and spatial resolution for multichannel imaging
WO2002103335A1 (en) 2001-06-18 2002-12-27 Amnis Corporation Spectral deconvolution of fluorescent markers
AU2002326318A1 (en) * 2001-06-26 2003-03-03 Trustees Of Tufts College Targeting tumor cell antigens: antibodies useful for the diagnosis, prognosis, and treatment of cancer
WO2003009579A2 (en) 2001-07-17 2003-01-30 Amnis Corporation Computational methods for the segmentation of images of objects from background in a flow imaging instrument
EP1422526A1 (en) * 2002-10-28 2004-05-26 MTM Laboratories AG Method for improved diagnosis of dysplasias
WO2004065544A2 (en) 2003-01-15 2004-08-05 Amnis Corporation Cell suspension rotating fluidic pump
US20040260157A1 (en) 2003-06-20 2004-12-23 Montes Miguel A. Method for automated screening of cervical/endocervical malignant and premalignant epithelial lesions using flow cytometry with HPV DNA fluorescent in-situ hybridization ( FISH) technology
KR20080075045A (ko) * 2004-03-24 2008-08-13 트리패스 이미징, 인코포레이티드 자궁경부 질환의 검사 방법 및 조성물
US20050221399A1 (en) 2004-03-30 2005-10-06 Sysmex Corporation Method for screening cervical cancer
JP2005315862A (ja) * 2004-03-30 2005-11-10 Sysmex Corp 子宮頸癌のスクリーニング方法及び子宮頸癌診断薬
KR100633525B1 (ko) * 2004-10-04 2006-10-16 굿젠 주식회사 인체유두종바이러스의 프로브, 이를 포함하는올리고뉴클레오티드 마이크로어레이, 진단키트 및 이를이용한 유전자형 분석방법
DE102004052816A1 (de) 2004-10-29 2006-05-04 Mefro Räderwerk Ronneburg GmbH Spurverstellrad und Verfahren zur Herstellung eines Spurverstellrads
US8859218B2 (en) * 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
CN104122191B (zh) * 2007-10-29 2020-02-18 希森美康株式会社 细胞分析仪及细胞分析方法
US20100234445A1 (en) 2008-07-01 2010-09-16 Weng Onn Lui Patterns of known and novel small RNAS in human cervical cancer
WO2010013678A1 (ja) * 2008-07-30 2010-02-04 シスメックス株式会社 子宮頸部異常細胞検出用試薬及びそれを用いる子宮頸部異常細胞検出方法
EP3181705A1 (en) 2008-11-12 2017-06-21 Caris Life Sciences Switzerland Holdings GmbH Methods and systems of using exosomes for determining phenotypes
US8865882B2 (en) 2010-09-08 2014-10-21 Cancer Genetics, Inc. Methods for detecting human papilloma virus-associated cancers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006052822A2 (en) * 2004-11-05 2006-05-18 Cytolution, Inc. Methods and devices for screening cervical cancer
WO2006084155A1 (en) * 2005-02-02 2006-08-10 Patterson Bruce K Hpv e6, e7 mrna assay and methods of use thereof
CN101831490A (zh) * 2009-03-12 2010-09-15 上海市第八人民医院 一种利用pax1和cdh1基因甲基化检测宫颈癌的方法和试剂盒

Also Published As

Publication number Publication date
CN103270419A (zh) 2013-08-28
WO2012065004A3 (en) 2012-07-05
ES2627069T3 (es) 2017-07-26
US20170130281A1 (en) 2017-05-11
JP2017058379A (ja) 2017-03-23
JP6505657B2 (ja) 2019-04-24
EP2638396B1 (en) 2017-03-01
US10167526B2 (en) 2019-01-01
CN107699618B (zh) 2021-08-20
EP2638396A4 (en) 2014-04-30
US20120122078A1 (en) 2012-05-17
JP2019124701A (ja) 2019-07-25
JP2013542452A (ja) 2013-11-21
JP6109744B2 (ja) 2017-04-05
EP2638396A2 (en) 2013-09-18
CN107699618A (zh) 2018-02-16
WO2012065004A2 (en) 2012-05-18
EP3217178A3 (en) 2017-11-22
US10011884B2 (en) 2018-07-03
US20150259756A1 (en) 2015-09-17
EP3217178A2 (en) 2017-09-13

Similar Documents

Publication Publication Date Title
CN103270419B (zh) 用于通过宫颈细胞的悬液样本预测受试者是否具有宫颈上皮内瘤样(cin)病变的方法和系统
Westra Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas
Iftner et al. Chapter 12: Human papillomavirus technologies
Heselmeyer-Haddad et al. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia
US20190211382A1 (en) Method and System for Automated Image Analysis in Cancer Cells
US20040260157A1 (en) Method for automated screening of cervical/endocervical malignant and premalignant epithelial lesions using flow cytometry with HPV DNA fluorescent in-situ hybridization ( FISH) technology
Mirghani et al. Diagnosis of HPV driven oropharyngeal cancers: comparing p16 based algorithms with the RNAscope HPV-test
JP2001526045A (ja) ヒトパピローマウイルス関連疾患の評価
Westra Detection of human papillomavirus in clinical samples
Zappacosta et al. Chromogenic In Situ Hybridization and p16/Ki67 Dual Staining on Formalin‐Fixed Paraffin‐Embedded Cervical Specimens: Correlation with HPV‐DNA Test, E6/E7 mRNA Test, and Potential Clinical Applications
US20140357509A1 (en) Differentiation between transient and persistent high-risk hpv infection by in situ hybridization
CN107850526B (zh) 评估细胞乳腺样品的方法和用于实践所述方法的组合物
Jarboe et al. Cytomorphologic diagnosis and HPV testing of metastatic and primary oropharyngeal squamous cell carcinomas: A review and summary of the literature
Goyal et al. p16 positive histologically bland squamous metaplasia of the cervix: what does it signify?
CA3119710A1 (en) Compositions and methods for detecting human papillomavirus
Hemstreet III et al. Quantitative fluorescence image analysis in bladder cancer screening
Ling et al. Application of flow cytometry for biomarker‐based cervical cancer cells detection
US8586296B2 (en) Method to identify and predict disease progression of human papilloma virus-infected lesions
Wilson et al. The utility of high-risk human papillomavirus E6/E7 mRNA in situ hybridization in assessing HPV status on cell block
HK1188628A (en) Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (cin) lesion from a suspension sample of cervical cells
HK1188628B (en) Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (cin) lesion from a suspension sample of cervical cells
JP2006521104A (ja) 癌腫の早期診断法及びこれを行うための検査キット
Nassar et al. Comparison of p16INK4A and Hybrid Capture® 2 human papillomavirus testing as adjunctive tests in liquid‐based gynecologic SurePath™ preparations
Hajrović et al. Detection of hrHPV DNA with Simulated HPV16 and HPV18 Typing Based on Real-Time PCR
Zappacosta et al. Research Article Chromogenic In Situ Hybridization and p16/Ki67 Dual Staining on Formalin-Fixed Paraffin-Embedded Cervical Specimens: Correlation with HPV-DNA Test, E6/E7 mRNA Test, and Potential Clinical Applications

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1188628

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1188628

Country of ref document: HK

EE01 Entry into force of recordation of patent licensing contract
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20130828

Assignee: GUANGZHOU IMPROVE MEDICAL TECHNOLOGY Co.,Ltd.

Assignor: INCELLDX, INC.

Contract record no.: X2019990000041

Denomination of invention: METHODS AND SYSTEMS FOR PREDICTING WHETHER A SUBJECT HAS A CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) LESION FROM A SUSPENSION SAMPLE OF CERVICAL CELLS

Granted publication date: 20171205

License type: Exclusive License

Record date: 20190823

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20171205